Alpha Teknova, Inc. (TKNO) Financials
TKNO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 138.4 million | 38.7 million |
2023-06-30 | 132.5 million | 46.3 million |
2023-03-31 | 141.0 million | 48.9 million |
2022-12-31 | 152.3 million | 52.4 million |
TKNO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.4 million | 1.0 million |
2023-06-30 | -6.2 million | 1.1 million |
2023-03-31 | -12.0 million | 1.0 million |
2022-12-31 | -12.8 million | 1.0 million |
TKNO Net Income
No data available :(
TKNO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 32.1 million | - | 17.6 million |
2023-06-30 | 23.7 million | - | 18.1 million |
2023-03-31 | 30.2 million | 22.0 million | 18.9 million |
2022-12-31 | 42.2 million | - | 20.3 million |
TKNO Shares Outstanding
TKNO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 972000 | 1.4 million | 6.1 million | 2.4 million |
2023-06-30 | 2.3 million | 1.5 million | 5.9 million | 2.2 million |
2023-03-31 | 4.3 million | 1.4 million | 7.3 million | 2.3 million |
2022-12-31 | 4.7 million | 1.9 million | 7.4 million | 2.6 million |
TKNO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 8.2 million | 6.7 million |
2023-06-30 | 11.5 million | 6.5 million |
2023-03-31 | 9.1 million | 6.7 million |
2022-12-31 | 7.9 million | 5.8 million |
TKNO
Price: $2
52 week price:
Earnings Per Share: -1.38 USD
P/E Ratio: -2.55
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 32300
Market Capitalization: 104.6 million